Sunmark Camphor Spirit

Camphor 10%


Strategic Sourcing Services Llc
Human Otc Drug
NDC 49348-148
Sunmark Camphor Spirit also known as Camphor 10% is a human otc drug labeled by 'Strategic Sourcing Services Llc'. National Drug Code (NDC) number for Sunmark Camphor Spirit is 49348-148. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Sunmark Camphor Spirit drug includes Camphor (natural) - 100 mg/mL . The currest status of Sunmark Camphor Spirit drug is Active.

Drug Information:

Drug NDC: 49348-148
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name: Sunmark Camphor Spirit
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type: Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name: Camphor 10%
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name: Strategic Sourcing Services Llc
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form: Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status: Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:CAMPHOR (NATURAL) - 100 mg/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:TOPICAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Marketing Category: OTC MONOGRAPH NOT FINAL
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date: 01 Jan, 2008
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date: 25 Dec, 2025
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Application Number: part348
This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
Listing Expiration Date: 31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
Manufacturer Name:Strategic Sourcing Services LLC
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
RxCUI:204935
The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms.
Original Packager:Yes
Whether or not the drug has been repackaged for distribution.
UPC:0010939149336
UPC stands for Universal Product Code.
UNII:N20HL7Q941
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDCDescriptionMarketing Start DateMarketing End DateSample Available
49348-148-3059 mL in 1 BOTTLE, PLASTIC (49348-148-30)12 Dec, 2017N/ANo
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Purpose:

Purpose counterirritant

Product Elements:

Sunmark camphor spirit camphor 10% alcohol water camphor (natural) camphor (natural)

Indications and Usage:

Use for the temporary relief of minor aches, muscle and joint pain associated with arthritis, strains, brusies and simple backache.

Warnings:

Warnings for external use only. do not drink. if swallowed, immediately give 3 or 4 glases of water. do not induce vomiting. if vomiting occurs, give fluids again. do not give anything by mouth to an unconscious or convulsing person. get medical attention immediately. avoid contact with eyes or mucous membranes. do not apply to irritated skin.

When Using:

When using this product do not bandage tightly.

Dosage and Administration:

Directions (dilute 3 parts olive oil and mix well) adults and children 2 yrs. and older. apply to th affected area not more than 3 or 4 times daily. children under 2 yrs of age: consult a doctor befre use.

Stop Use:

Discontinue use and consult a doctor if condition worsens, or if excesive irritation develops. symptoms persit for more than 7 days, or clear up and occur again within a few days.

Package Label Principal Display Panel:

Principal display panel camphor spirits, usp label

Further Questions:

Questions or comments? 1-800-662-3435


Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.